clinical trial · NCT00967746
An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)
Organon and Co·phase2·completed·n = 84
ContraceptionEtonogestrel-releasing IUSEtonogestrel-releasing IUSEtonogestrel-releasing IUSMultiload-cu 375®
brief summary
This is a phase 2, randomized, active-controlled, parallel-group, multicenter, single-blind trial of three different doses of etonogestrel releasing medicated intrauterine systems (ENG-MIUS) in healthy parous women in need for contraception. The primary trial objective is to explore safety and acceptability of three doses of an ENG-releasing medicated intrauterine system (ENG-MIUS) as compared to Multiload-cu 375®.
started
Nov 1, 2009
primary completion
Nov 1, 2010
completion
Jul 1, 2011
last updated
Apr 8, 2026
official title
A Randomized, Multicenter, Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Doses of an Etonogestrel-releasing Medicated Intrauterine System (ENG-MIUS) Versus a Copper-releasing Intrauterine Device (IUD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol